Is opt-out enrolment acceptable for low-risk digital health services?


Journal

Journal of primary health care
ISSN: 1172-6156
Titre abrégé: J Prim Health Care
Pays: Australia
ID NLM: 101524060

Informations de publication

Date de publication:
12 2022
Historique:
received: 21 07 2022
accepted: 06 09 2022
entrez: 2 1 2023
pubmed: 3 1 2023
medline: 5 1 2023
Statut: ppublish

Résumé

Introduction Digital health programmes not only complement existing services, but have the potential to reach populations that existing services are not reaching. Many of these services require people to opt-in to receive them, which presents significant barriers to access. An alternative is to make low-risk digital services opt-out, ensuring appropriate members of the target audience are signed up for a service unless they select to not receive it. Aim This study aimed to investigate how changing enrolment in a low-risk digital health programme from opt-in to opt-out would impact on enrolment and dropout rates. Methods This study involved the retrospective analysis of registration data from txtpēpi, a maternal and child health text-message programme. System-recorded data from enrolments during a 12-month period were obtained. In the first 6 months, users had to opt-in to the service (Period 1), but in the following 6 months, an opt-out process was implemented (Period 2). Results There was a 77% increase in enrolments in Period 2 (n  = 113) compared to Period 1 (n  = 64) and no significant change in the proportion of enrolments of Māori between time periods (P  = 0.508). There was no significant difference in withdrawal rates between time periods at either 2 weeks (5% vs 6%, P  = 0.676) or 1 month (9% vs 9%, P  = 0.907). Discussion This study has shown switching from an opt-in to an opt-out option resulted in an increase in enrolments in an mHealth programme, but had no impact on withdrawals. This indicates that employing opt-out enrolment for low-risk evidence-based interventions is acceptable and a potential way to make these services more accessible.

Identifiants

pubmed: 36592779
pii: HC22088
doi: 10.1071/HC22088
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

368-371

Auteurs

Rosie Dobson (R)

National Institute for Health Innovation, University of Auckland, Auckland, Aotearoa New Zealand; and Te Whatu Ora - Waitemata, Auckland, Aotearoa New Zealand.

Amanda Uri (A)

National Institute for Health Innovation, University of Auckland, Auckland, Aotearoa New Zealand; and Te Arawa Whanau Ora, Rotorua, Aotearoa New Zealand.

Robyn Whittaker (R)

National Institute for Health Innovation, University of Auckland, Auckland, Aotearoa New Zealand; and Te Whatu Ora - Waitemata, Auckland, Aotearoa New Zealand.

Karen Evison (K)

Te Whatu Ora - Lakes, Rotorua, Aotearoa New Zealand.

Elaine Umali (E)

National Institute for Health Innovation, University of Auckland, Auckland, Aotearoa New Zealand.

Hayden McRobbie (H)

Te Whatu Ora - Lakes, Rotorua, Aotearoa New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH